Parkinson's Disease Treatment With Coenzyme Q10
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00004731 |
Recruitment Status :
Completed
First Posted : February 28, 2000
Last Update Posted : June 24, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Parkinson's Disease | Drug: Coenzyme Q10 | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | Effects of Coenzyme Q10 in Early Parkinson's Disease |
Study Start Date : | September 1998 |
Study Completion Date : | October 2003 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The subjects must have the three cardinal features of PD: slowness of movement, resting tremor and rigidity. The signs of PD must be greater on one side.
Exclusion Criteria:
- Disorders that mimic PD.
- Other serious medical problems.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00004731
United States, New York | |
University of Rochester | |
Rochester, New York, United States, 14620 |
Principal Investigator: | Clifford W. Shults, M.D. | University of California, San Diego |
ClinicalTrials.gov Identifier: | NCT00004731 |
Other Study ID Numbers: |
R01NS036714 ( U.S. NIH Grant/Contract ) |
First Posted: | February 28, 2000 Key Record Dates |
Last Update Posted: | June 24, 2005 |
Last Verified: | December 2003 |
Parkinson's disease coenzyme Q10 |
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Nervous System Diseases Movement Disorders |
Synucleinopathies Neurodegenerative Diseases Ubiquinone Coenzyme Q10 Micronutrients Physiological Effects of Drugs Vitamins |